APL-030

DB18735ExperimentalSmall molecule

APL-030 is a orally-active small molecule inhibitor of GCN2.

Code names
APL 030

Which companies are running trials of APL-030, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In